The present report describes for the first time CMV- and EBV-specific immune responses—characterized by antigen-specific IFNγ production and humoral immune responses—in chemotherapy-naïve patients with pancreatic cancer or brain tumor. Here, IFNG is linked to familial pancreatic carcinoma.